Home » Topics » Regulatory » Patents

Patents
RSS

Takeda Pharmaceutical presents GluN2B receptor inhibitors

July 8, 2016

Akarna Therapeutics discloses farnesoid X receptor agonists

July 8, 2016

Forendo Pharma Oy patents 17beta-HSD1 inhibitors

July 8, 2016

Bayer Healthcare develops Mnk1 inhibitors

July 8, 2016

Alios BioPharma patents NS5B inhibitors

July 7, 2016

Celgene divulges ERK inhibitors

July 7, 2016

Shanghai Haiyan Pharmaceutical Technology and Yangtze River Pharmaceutical disclose PI3K inhibitors

July 7, 2016

Roche and Genentech report ERalpha antagonists and destabilizers

July 7, 2016

Merck & Co. patents orexin receptor inhibitors

July 7, 2016

ADT Pharmaceuticals announces RAS Gtpase inhibitors

July 7, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...